Inhibition of IFN-gamma production by intravenous immunoglobulins during mixed lymphocyte reaction: consequences for proliferation and TNF-gamma production.
Toungouz
M
M
Department of Immunology and Transfusion, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
Denys
C
C
Dupont
E
E
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology*; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000494:pharmacology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D011994:Recombinant Proteins / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D000911:Antibodies, Monoclonal; D016756:Immunoglobulins, Intravenous; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma